Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065774

SVP and General Counsel sold 6,530 shares at an average $57.86 ($377,797)

  • SVP and General Counsel acquired 6,530 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Stacy L SVP and General Counsel 2020-12-31 Option exercise +4,759 $7.80 $37,120 6,059 D: show line 1 in the form
Taylor Stacy L SVP and General Counsel 2020-12-31 Option exercise +1,771 $6.55 $11,600 7,830 D: show line 2 in the form
Taylor Stacy L SVP and General Counsel 2020-12-31 Sale −4,529 $57.54 $260,599 3,301 D: show line 3 in the form
Taylor Stacy L SVP and General Counsel 2020-12-31 Sale −1,610 $58.40 $94,024 1,691 D: show line 4 in the form
Taylor Stacy L SVP and General Counsel 2020-12-31 Sale −391 $59.27 $23,175 1,300 D: show line 5 in the form
Open-market sales · 6,530 sh · avg $57.86 · $377,797

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Stacy L SVP and General Counsel 2020-12-31 Option exercise · Stock Option (Right to Buy) −4,759 29,167 D: show line 6 in the form
Taylor Stacy L SVP and General Counsel 2020-12-31 Option exercise · Stock Option (Right to Buy) −1,771 26,563 D: show line 7 in the form
Loading xslF345X03/doc4.xml…